日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells

靶向甲羟戊酸通路或Wnt通路以克服TP53突变型急性髓系白血病(AML)细胞的CAR-T细胞耐药性

Jan Mueller # ,Roman R Schimmer # ,Christian Koch ,Florin Schneiter ,Jonas Fullin ,Veronika Lysenko ,Christian Pellegrino ,Nancy Klemm ,Norman Russkamp ,Renier Myburgh ,Laura Volta ,Alexandre Pa Theocharides ,Kari J Kurppa ,Benjamin L Ebert ,Timm Schroeder ,Markus G Manz # ,Steffen Boettcher #

Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors

肽引导的衔接子CAR-T细胞疗法治疗表达SSTR2的神经内分泌肿瘤

Christian Pellegrino, Nicholas Favalli, Laura Volta, Ramon Benz, Sara Puglioli, Gabriele Bassi, Kathrin Zitzmann, Christoph Josef Auernhammer, Svenja Nölting, Chiara F Magnani, Dario Neri, Felix Beuschlein, Markus G Manz

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

含有安全开关的抗 CD117 CAR-T 细胞可消灭人类急性髓系白血病和造血干细胞

Chiara F Magnani, Renier Myburgh, Silvan Brunn, Morgane Chambovey, Marianna Ponzo, Laura Volta, Francesco Manfredi, Christian Pellegrino, Steve Pascolo, Csaba Miskey, Zoltán Ivics, Judith A Shizuru, Dario Neri, Markus G Manz